The efficacy and safety of two low-dose peri-operative dexamethasone on pain and recovery following total hip arthroplasty: a randomized controlled trial

International Orthopaedics

Volumn 42, Issue 3, 2018, Pages 499-505

  Lei, Yi ting ^a   Xu, Bin ^a   Xie, Xiao wei ^a   Xie, Jin wei ^a   Huang, Qiang ^a   Pei, Fu xing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Dexamethasone; Efficacy; Randomized controlled trial; Total hip arthroplasty

Indexed keywords

ANTIEMETIC AGENT; C REACTIVE PROTEIN; DEXAMETHASONE; DICLOFENAC; ENOXAPARIN; INTERLEUKIN 6; METOCLOPRAMIDE; MOSAPRIDE; ONDANSETRON; OXYCODONE; PARECOXIB; PLACEBO; PREGABALIN; RIVAROXABAN; ANALGESIC AGENT; GLUCOCORTICOID;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HUMAN; INFLAMMATION; LENGTH OF STAY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM; VISUAL ANALOG SCALE; WOUND HEALING IMPAIRMENT; AGED; BLOOD; DOUBLE BLIND PROCEDURE; HIP REPLACEMENT; JOINT CHARACTERISTICS AND FUNCTIONS; METABOLISM; MIDDLE AGED; PAIN MEASUREMENT; PROCEDURES; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; AGED; ANALGESICS; ANTIEMETICS; ARTHROPLASTY, REPLACEMENT, HIP; C-REACTIVE PROTEIN; DEXAMETHASONE; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-6; LENGTH OF STAY; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; POSTOPERATIVE NAUSEA AND VOMITING; PROSPECTIVE STUDIES; RANGE OF MOTION, ARTICULAR; TREATMENT OUTCOME;

EID: 85021208551     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-017-3537-8     Document Type: Article

References (24)

1. Yue C, Kang P, Yang P, Xie J, Pei F (2014) Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplast 29(12):2452–2456. doi:10.1016/j.arth.2014.03.032
2. Wasko MK, Bobecka-Wesolowska K, Tomasiuk R, Kowalczewski J (2015) Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty. Clin Chem Lab Med 53(11):1785–1792. doi:10.1515/cclm-2014-1055
3. Aasvang EK, Luna IE, Kehlet H (2015) Challenges in postdischarge function and recovery: the case of fast-track hip and knee arthroplasty. Br J Anaesth 115(6):861–866. doi:10.1093/bja/aev257
4. Richardson AB, Bala A, Wellman SS, Attarian DE, Bolognesi MP, Grant SA (2016) Perioperative dexamethasone administration does not increase the incidence of postoperative infection in Total hip and knee Arthroplasty: a retrospective analysis. J Arthroplast 31(8):1784–1787. doi:10.1016/j.arth.2016.01.028
5. Bolac CS, Wallace AH, Broadwater G, Havrilesky LJ, Habib AS (2013) The impact of postoperative nausea and vomiting prophylaxis with dexamethasone on postoperative wound complications in patients undergoing laparotomy for endometrial cancer. Anesth Analg 116(5):1041–1047. doi:10.1213/ANE.0b013e318276cf58
6. Chen CC, Siddiqui FJ, Chen TL, Chan ES, Tam KW (2012) Dexamethasone for prevention of postoperative nausea and vomiting in patients undergoing thyroidectomy: meta-analysis of randomized controlled trials. World J Surg 36(1):61–68. doi:10.1007/s00268-011-1343-9
7. Romundstad L, Breivik H, Roald H, Skolleborg K, Haugen T, Narum J, Stubhaug A (2006) Methylprednisolone reduces pain, emesis, and fatigue after breast augmentation surgery: a single-dose, randomized, parallel-group study with methylprednisolone 125 mg, parecoxib 40 mg, and placebo. Anesth Analg 102(2):418–425. doi:10.1213/01.ane.0000194358.46119.e1
8. Lunn TH, Andersen LO, Kristensen BB, Husted H, Gaarn-Larsen L, Bandholm T, Ladelund S, Kehlet H (2013) Effect of high-dose preoperative methylprednisolone on recovery after total hip arthroplasty: a randomized, double-blind, placebo-controlled trial. Br J Anaesth 110(1):66–73. doi:10.1093/bja/aes345
9. Backes JR, Bentley JC, Politi JR, Chambers BT (2013) Dexamethasone reduces length of hospitalization and improves postoperative pain and nausea after total joint arthroplasty: a prospective, randomized controlled trial. J Arthroplast 28(8 Suppl):11–17. doi:10.1016/j.arth.2013.05.041
10. Miyagawa Y, Ejiri M, Kuzuya T, Osada T, Ishiguro N, Yamada K (2010) Methylprednisolone reduces postoperative nausea in total knee and hip arthroplasty. J Clin Pharm Ther 35(6):679–684. doi:10.1111/j.1365-2710.2009.01141.x
11. Romundstad L, Breivik H, Niemi G, Helle A, Stubhaug A (2004) Methylprednisolone intravenously 1 day after surgery has sustained analgesic and opioid-sparing effects. Acta Anaesthesiol Scand 48(10):1223–1231. doi:10.1111/j.1399-6576.2004.00480.x
12. Lunn TH, Kehlet H (2013) Perioperative glucocorticoids in hip and knee surgery - benefit vs. harm? A review of randomized clinical trials. Acta Anaesthesiol Scand 57(7):823–834. doi:10.1111/aas.12115
13. De Oliveira GS Jr, Almeida MD, Benzon HT, McCarthy RJ (2011) Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology 115(3):575–588. doi:10.1097/ALN.0b013e31822a24c2
14. Kardash KJ, Sarrazin F, Tessler MJ, Velly AM (2008) Single-dose dexamethasone reduces dynamic pain after total hip arthroplasty. Anesth Analg 106(4):1253–1257, table of contents. doi:10.1213/ANE.0b013e318164f319
15. Bergeron SG, Kardash KJ, Huk OL, Zukor DJ, Antoniou J (2009) Perioperative dexamethasone does not affect functional outcome in total hip arthroplasty. Clin Orthop Relat Res 467(6):1463–1467. doi:10.1007/s11999-009-0733-x
16. Cui Z, Liu X, Teng Y, Jiang J, Wang J, Xia Y (2015) The efficacy of steroid injection in total knee or hip arthroplasty. Knee Surg Sports Traumatol Arthrosc 23(8):2306–2314. doi:10.1007/s00167-014-3049-7
17. Spies CM, Strehl C, van der Goes MC, Bijlsma JW, Buttgereit F (2011) Glucocorticoids. Best Pract Res Clin Rheumatol 25(6):891–900. doi:10.1016/j.berh.2011.11.002
18. Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335(1):2–13. doi:10.1016/j.mce.2010.04.005
19. Louati K, Berenbaum F (2015) Fatigue in chronic inflammation — a link to pain pathways. Arthritis Res Ther 17:254. doi:10.1186/s13075-015-0784-1
20. Sculco PK, McLawhorn AS, Desai N, Su EP, Padgett DE, Jules-Elysee K (2016) The effect of perioperative corticosteroids in Total hip Arthroplasty: a prospective double-blind placebo controlled pilot study. J Arthroplast 31(6):1208–1212. doi:10.1016/j.arth.2015.11.011
21. Mathiesen O, Jacobsen LS, Holm HE, Randall S, Adamiec-Malmstroem L, Graungaard BK, Holst PE, Hilsted KL, Dahl JB (2008) Pregabalin and dexamethasone for postoperative pain control: a randomized controlled study in hip arthroplasty. Br J Anaesth 101(4):535–541. doi:10.1093/bja/aen215
22. Nostdahl T, Bernklev T, Raeder J, Sandvik L, Fredheim O (2016) Postoperative fatigue; translation and validation of a revised 10-item short form of the Identity-Consequence fatigue scale (ICFS). J Psychosom Res 84:1–7. doi:10.1016/j.jpsychores.2016.03.002
23. Rubin GJ, Hotopf M (2002) Systematic review and meta-analysis of interventions for postoperative fatigue. Br J Surg 89(8):971–984. doi:10.1046/j.1365-2168.2002.02138.x
24. Sibia US, MacDonald JH, King PJ (2016) Predictors of hospital length of stay in an enhanced recovery after surgery program for primary total hip arthroplasty. J Arthroplast 31(10):2119–2123. doi:10.1016/j.arth.2016.02.060